|
NNE MADE PROFIT IN 2003 – IN SPITE OF A LARGE DROP IN TURNOVER
16 March 2004 - NNE A/S
| In 2003 NNE experienced a significant reduction of activities. This had a considerable impact on the result of the year, leaving a pre-tax profit of DKK 4.2 million. Net turnover in 2003 was approx. DKK 960 million, which is 26% below the record turnover of DKK 1.3 billion in 2002. Pre-tax profit margin dropped to 0.4%. |
In 2003 NNE experienced a significant reduction of activities. This had a considerable impact on the result of the year, leaving a pre-tax profit of DKK 4.2 million. Net turnover in 2003 was approx. DKK 960 million, which is 26% below the record turnover of DKK 1.3 billion in 2002. Pre-tax profit margin dropped to 0.4%. A moderate activity level was foreseen, but it turned out to be significantly lower than expected, mainly due to repeated reductions in the investment plans of NNE's largest client, Novo Nordisk. General Manager of NNE, Hans Ole Voigt, comments: - The result is not satisfactory, and we can make it better. We expect to increase the profit margin significantly in 2004. But I am pleased to see that turnover to clients outside Novo Nordisk was DKK 140 million in 2003, an increase of 40% from 2002 – and a clear result of our strategy to expand our portfolio of national and international clients. NNE has just published its Annual Review 2003, which includes an account of the internationalization outlook.
http://nne.dk/
About: NNE A/S
With more than 80 years of experience, the engineering company NNE is a leading supplier of systems, consultancy and engineering services to the international pharmaceutical and biotechnological industry.Our competencies span all technical disciplines applying to engineering, construction, validation, start-up and optimisation, and reconstruction of facilities for product development and production plants, pilot plants and laboratories within the pharmaceutical and biotechnological field. Our unmistakable, clear client focus, combined with a flexible and integrated organisation where engineers, architects and pharmacists work closely together, puts us in a position to deliver customised solutions, ranging from stand-alone services to turnkey plants - quickly and safely. NNE operates at an international level. We have worked on and completed a large number of projects both in Denmark and the rest of Scandinavia, and we have constructed biotechnological and pharmaceutical production facilities in USA, China, Japan, Brazil, and France. |
More News:
• For March 2004
• From NNE A/S
• For Medical Equipment
|
